Piqray is a medication that is commonly prescribed to patients with advanced breast cancer that is hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-). The recommended daily dose of Piqray is 300mg, which is typically taken orally once a day with food.

This medication works by inhibiting a specific enzyme called phosphoinositide 3-kinase (PI3K), which plays a key role in the growth and spread of cancer cells. By blocking this enzyme, Piqray helps to slow down the progression of the disease and improve outcomes for patients.

It is important to follow your healthcare provider’s instructions carefully when taking Piqray. Be sure to take the medication at the same time each day and with food to help minimize any potential side effects. It is also important to avoid grapefruit and grapefruit juice while taking Piqray, as they can interact with the medication and increase the risk of side effects.

Like all medications, Piqray can cause side effects in some patients. Common side effects may include nausea, diarrhea, rash, and elevated blood sugar levels. It is important to report any side effects to your healthcare provider so that they can be properly managed.

Overall, Piqray is an important treatment option for patients with advanced breast cancer and can help to improve quality of life and extend survival. If you have been prescribed Piqray, be sure to take it as directed and communicate openly with your healthcare team about any concerns or questions you may have.